Annual CFF
$11.60 M
+$8.52 M+276.58%
31 December 2023
Summary:
Windtree Therapeutics annual cash flow from financing activities is currently $11.60 million, with the most recent change of +$8.52 million (+276.58%) on 31 December 2023. During the last 3 years, it has fallen by -$8.36 million (-41.90%). WINT annual CFF is now -88.46% below its all-time high of $100.45 million, reached on 31 December 2013.WINT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.59 M
+$560.00 K+54.16%
30 June 2024
Summary:
Windtree Therapeutics quarterly cash flow from financing activities is currently $1.59 million, with the most recent change of +$560.00 thousand (+54.16%) on 30 June 2024. Over the past year, it has increased by +$1.83 million (+784.12%). WINT quarterly CFF is now -97.89% below its all-time high of $75.54 million, reached on 31 December 2013.WINT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.92 M
-$9.12 M-75.78%
30 June 2024
Summary:
Windtree Therapeutics TTM cash flow from financing activities is currently $2.92 million, with the most recent change of -$9.12 million (-75.78%) on 30 June 2024. Over the past year, it has dropped by -$9.27 million (-76.08%). WINT TTM CFF is now -97.10% below its all-time high of $100.45 million, reached on 31 December 2013.WINT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
WINT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +276.6% | +784.1% | -76.1% |
| 3 y3 years | -41.9% | +4085.0% | -89.0% |
| 5 y5 years | -70.1% | +560.7% | -90.1% |
WINT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -60.5% | +276.6% | -85.1% | +784.1% | -90.1% | +75.2% |
| 5 y | 5 years | -70.1% | +276.6% | -94.2% | +240.2% | -93.9% | +75.2% |
| alltime | all time | -88.5% | >+9999.0% | -97.9% | +143.2% | -97.1% | +221.5% |
Windtree Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $1.59 M(+54.2%) | $2.92 M(-75.8%) |
| Mar 2024 | - | $1.03 M(+98.5%) | $12.04 M(+3.8%) |
| Dec 2023 | $11.60 M(+276.6%) | $521.00 K(-323.6%) | $11.60 M(-4.9%) |
| Sept 2023 | - | -$233.00 K(-102.2%) | $12.19 M(-10.2%) |
| June 2023 | - | $10.72 M(+1713.2%) | $13.58 M(+261.3%) |
| Mar 2023 | - | $591.00 K(-47.0%) | $3.76 M(+22.1%) |
| Dec 2022 | $3.08 M(-89.5%) | $1.12 M(-3.5%) | $3.08 M(-36.8%) |
| Sept 2022 | - | $1.16 M(+29.3%) | $4.88 M(+32.5%) |
| June 2022 | - | $895.00 K(-1105.6%) | $3.68 M(+121.0%) |
| Mar 2022 | - | -$89.00 K(-103.1%) | $1.66 M(-94.3%) |
| Dec 2021 | $29.36 M(+47.1%) | $2.91 M(-7380.0%) | $29.36 M(+10.8%) |
| Sept 2021 | - | -$40.00 K(-96.4%) | $26.50 M(+4.3%) |
| June 2021 | - | -$1.12 M(-104.1%) | $25.40 M(-46.8%) |
| Mar 2021 | - | $27.61 M(>+9900.0%) | $47.77 M(+139.3%) |
| Dec 2020 | $19.96 M(-8.3%) | $48.00 K(-104.2%) | $19.96 M(-53.2%) |
| Sept 2020 | - | -$1.14 M(-105.4%) | $42.65 M(-1.8%) |
| June 2020 | - | $21.25 M(<-9900.0%) | $43.44 M(+96.0%) |
| Mar 2020 | - | -$199.00 K(-100.9%) | $22.17 M(+1.8%) |
| Dec 2019 | $21.77 M(-43.8%) | $22.74 M(-6672.0%) | $21.77 M(-26.1%) |
| Sept 2019 | - | -$346.00 K(+1181.5%) | $29.45 M(-11.0%) |
| June 2019 | - | -$27.00 K(-95.5%) | $33.07 M(-7.2%) |
| Mar 2019 | - | -$598.00 K(-102.0%) | $35.64 M(-8.0%) |
| Dec 2018 | $38.74 M(+124.0%) | $30.42 M(+827.3%) | $38.74 M(+193.6%) |
| Sept 2018 | - | $3.28 M(+29.1%) | $13.19 M(+5.4%) |
| June 2018 | - | $2.54 M(+1.6%) | $12.51 M(+25.0%) |
| Mar 2018 | - | $2.50 M(-48.7%) | $10.01 M(-42.1%) |
| Dec 2017 | $17.30 M(+2339.5%) | $4.87 M(+87.3%) | $17.30 M(+36.6%) |
| Sept 2017 | - | $2.60 M(+6566.7%) | $12.66 M(+21.0%) |
| June 2017 | - | $39.00 K(-99.6%) | $10.46 M(-0.3%) |
| Mar 2017 | - | $9.79 M(+4011.8%) | $10.49 M(+1380.3%) |
| Dec 2016 | $709.00 K(-97.4%) | $238.00 K(-40.8%) | $709.00 K(+50.5%) |
| Sept 2016 | - | $402.00 K(+482.6%) | $471.00 K(-98.3%) |
| June 2016 | - | $69.00 K(>+9900.0%) | $27.81 M(+0.3%) |
| Mar 2016 | - | $0.00(0.0%) | $27.72 M(+0.1%) |
| Dec 2015 | $27.70 M(+7248.3%) | $0.00(-100.0%) | $27.70 M(+0.1%) |
| Sept 2015 | - | $27.74 M(<-9900.0%) | $27.68 M(<-9900.0%) |
| June 2015 | - | -$21.00 K(+5.0%) | -$79.00 K(+1.3%) |
| Mar 2015 | - | -$20.00 K(-4.8%) | -$78.00 K(-120.7%) |
| Dec 2014 | $377.00 K(-99.6%) | -$21.00 K(+23.5%) | $377.00 K(-99.5%) |
| Sept 2014 | - | -$17.00 K(-15.0%) | $75.94 M(-0.0%) |
| June 2014 | - | -$20.00 K(-104.6%) | $75.94 M(-16.6%) |
| Mar 2014 | - | $435.00 K(-99.4%) | $91.06 M(-9.4%) |
| Dec 2013 | $100.45 M(+100.0%) | $75.54 M(<-9900.0%) | $100.45 M(+304.4%) |
| Sept 2013 | - | -$15.00 K(-100.1%) | $24.84 M(+0.0%) |
| June 2013 | - | $15.09 M(+53.5%) | $24.84 M(+154.5%) |
| Mar 2013 | - | $9.83 M(<-9900.0%) | $9.76 M(-80.6%) |
| Dec 2012 | $50.22 M(+120.5%) | -$66.00 K(+266.7%) | $50.22 M(-0.8%) |
| Sept 2012 | - | -$18.00 K(-280.0%) | $50.61 M(+0.0%) |
| June 2012 | - | $10.00 K(-100.0%) | $50.59 M(+0.1%) |
| Mar 2012 | - | $50.30 M(>+9900.0%) | $50.53 M(+121.8%) |
| Dec 2011 | $22.78 M(+20.9%) | $320.00 K(-964.9%) | $22.78 M(-3.6%) |
| Sept 2011 | - | -$37.00 K(-21.3%) | $23.63 M(+18.3%) |
| June 2011 | - | -$47.00 K(-100.2%) | $19.97 M(-24.6%) |
| Mar 2011 | - | $22.55 M(+1838.6%) | $26.50 M(+40.7%) |
| Dec 2010 | $18.84 M(+2.9%) | $1.16 M(-131.5%) | $18.84 M(-13.5%) |
| Sept 2010 | - | -$3.69 M(-156.9%) | $21.77 M(-17.6%) |
| June 2010 | - | $6.49 M(-56.4%) | $26.42 M(-16.1%) |
| Mar 2010 | - | $14.89 M(+263.4%) | $31.49 M(+72.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $18.31 M(+335.0%) | $4.10 M(+330.7%) | $18.31 M(+18.3%) |
| Sept 2009 | - | $951.00 K(-91.8%) | $15.47 M(-17.0%) |
| June 2009 | - | $11.56 M(+578.0%) | $18.64 M(+193.4%) |
| Mar 2009 | - | $1.71 M(+35.5%) | $6.35 M(+50.9%) |
| Dec 2008 | $4.21 M(-93.0%) | $1.26 M(-69.4%) | $4.21 M(-86.9%) |
| Sept 2008 | - | $4.12 M(-667.6%) | $32.24 M(+11.8%) |
| June 2008 | - | -$725.00 K(+65.5%) | $28.83 M(-50.1%) |
| Mar 2008 | - | -$438.00 K(-101.5%) | $57.77 M(-3.3%) |
| Dec 2007 | $59.72 M(+243.9%) | $29.29 M(+4024.9%) | $59.72 M(+32.4%) |
| Sept 2007 | - | $710.00 K(-97.5%) | $45.10 M(+2.4%) |
| June 2007 | - | $28.21 M(+1767.3%) | $44.03 M(+140.2%) |
| Mar 2007 | - | $1.51 M(-89.7%) | $18.33 M(+5.6%) |
| Dec 2006 | $17.37 M(-77.4%) | $14.67 M(-4185.8%) | $17.37 M(-45.1%) |
| Sept 2006 | - | -$359.00 K(-114.3%) | $31.62 M(-36.1%) |
| June 2006 | - | $2.51 M(+363.0%) | $49.46 M(+4.5%) |
| Mar 2006 | - | $543.00 K(-98.1%) | $47.35 M(-38.5%) |
| Dec 2005 | $76.98 M(+97.1%) | $28.92 M(+65.4%) | $76.98 M(+37.9%) |
| Sept 2005 | - | $17.49 M(+4282.7%) | $55.81 M(+41.3%) |
| June 2005 | - | $399.00 K(-98.7%) | $39.50 M(-40.1%) |
| Mar 2005 | - | $30.18 M(+289.5%) | $65.94 M(+68.8%) |
| Dec 2004 | $39.05 M(+10.6%) | $7.75 M(+556.6%) | $39.05 M(+15.8%) |
| Sept 2004 | - | $1.18 M(-95.6%) | $33.71 M(-13.5%) |
| June 2004 | - | $26.83 M(+715.4%) | $38.99 M(+1.2%) |
| Mar 2004 | - | $3.29 M(+36.8%) | $38.51 M(+9.1%) |
| Dec 2003 | $35.31 M(+120.0%) | $2.41 M(-62.8%) | $35.31 M(-21.2%) |
| Sept 2003 | - | $6.46 M(-75.5%) | $44.78 M(+13.1%) |
| June 2003 | - | $26.36 M(>+9900.0%) | $39.59 M(+192.6%) |
| Mar 2003 | - | $83.00 K(-99.3%) | $13.53 M(-15.7%) |
| Dec 2002 | $16.05 M(+46.1%) | $11.88 M(+836.1%) | $16.05 M(+13.1%) |
| Sept 2002 | - | $1.27 M(+324.4%) | $14.19 M(+10.1%) |
| June 2002 | - | $299.00 K(-88.5%) | $12.89 M(-5.1%) |
| Mar 2002 | - | $2.60 M(-74.0%) | $13.59 M(+23.7%) |
| Dec 2001 | $10.98 M(-48.9%) | $10.02 M(<-9900.0%) | $10.98 M(+995.1%) |
| Sept 2001 | - | -$32.00 K(-103.2%) | $1.00 M(-5.8%) |
| June 2001 | - | $998.00 K(<-9900.0%) | $1.06 M(+404.7%) |
| Mar 2001 | - | -$5000.00(-111.9%) | $211.00 K(-99.0%) |
| Dec 2000 | $21.50 M(+466.0%) | $42.00 K(+40.0%) | $21.50 M(-2.1%) |
| Sept 2000 | - | $30.00 K(-79.2%) | $21.96 M(-9.4%) |
| June 2000 | - | $144.00 K(-99.3%) | $24.23 M(-3.4%) |
| Mar 2000 | - | $21.29 M(+4165.7%) | $25.09 M(+560.3%) |
| Dec 1999 | $3.80 M(-3899.0%) | $499.00 K(-78.3%) | $3.80 M(+18.7%) |
| Sept 1999 | - | $2.30 M(+130.0%) | $3.20 M(+255.6%) |
| June 1999 | - | $1.00 M(>+9900.0%) | $900.00 K(>+9900.0%) |
| Mar 1999 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 1998 | -$100.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) | -$100.00 K(-95.8%) |
| Sept 1998 | - | $0.00(-100.0%) | -$2.40 M(<-9900.0%) |
| June 1998 | - | $100.00 K(-200.0%) | $0.00(-100.0%) |
| Mar 1998 | - | -$100.00 K(-95.8%) | -$1.10 M(<-9900.0%) |
| Dec 1997 | $0.00(-100.0%) | -$2.40 M(-200.0%) | $0.00(-100.0%) |
| Sept 1997 | - | $2.40 M(-340.0%) | $2.40 M(+2300.0%) |
| June 1997 | - | -$1.00 M(-200.0%) | $100.00 K(-90.9%) |
| Mar 1997 | - | $1.00 M(>+9900.0%) | $1.10 M(+1000.0%) |
| Dec 1996 | $100.00 K(-98.4%) | $0.00(-100.0%) | $100.00 K(0.0%) |
| Sept 1996 | - | $100.00 K(>+9900.0%) | $100.00 K(>+9900.0%) |
| June 1996 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1996 | - | $0.00(-100.0%) | $1.40 M(-12.5%) |
| Dec 1995 | $6.30 M | - | - |
| June 1995 | - | $1.40 M(+600.0%) | $1.60 M(+700.0%) |
| Mar 1995 | - | $200.00 K | $200.00 K |
FAQ
- What is Windtree Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Windtree Therapeutics?
- What is Windtree Therapeutics annual CFF year-on-year change?
- What is Windtree Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly CFF year-on-year change?
- What is Windtree Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Windtree Therapeutics?
- What is Windtree Therapeutics TTM CFF year-on-year change?
What is Windtree Therapeutics annual cash flow from financing activities?
The current annual CFF of WINT is $11.60 M
What is the all time high annual CFF for Windtree Therapeutics?
Windtree Therapeutics all-time high annual cash flow from financing activities is $100.45 M
What is Windtree Therapeutics annual CFF year-on-year change?
Over the past year, WINT annual cash flow from financing activities has changed by +$8.52 M (+276.58%)
What is Windtree Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of WINT is $1.59 M
What is the all time high quarterly CFF for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly cash flow from financing activities is $75.54 M
What is Windtree Therapeutics quarterly CFF year-on-year change?
Over the past year, WINT quarterly cash flow from financing activities has changed by +$1.83 M (+784.12%)
What is Windtree Therapeutics TTM cash flow from financing activities?
The current TTM CFF of WINT is $2.92 M
What is the all time high TTM CFF for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM cash flow from financing activities is $100.45 M
What is Windtree Therapeutics TTM CFF year-on-year change?
Over the past year, WINT TTM cash flow from financing activities has changed by -$9.27 M (-76.08%)